Table 2.
The list of articles included in the final review.
| Author | Year | Title |
|---|---|---|
| AlTakarli [32] | 2020 | China’s response to the COVID-19 outbreak: a model for epidemic preparedness and management |
| Anderson et al. [33] | 2020 | How will country-based mitigation measures influence the course of the COVID-19 epidemic? |
| Baker et al. [34] | 2021 | Elimination could be the optimal response strategy for COVID-19 and other emerging pandemic diseases |
| Burki [24] | 2022 | Dynamic zero COVID policy in the fight against COVID |
| Cai et al. [25] | 2022 | Modeling transmission of SARS-CoV-2 Omicron in China |
| Cai et al. [35] | 2022 | China’s ‘dynamic zero COVID-19 strategy’ will face greater challenges in the future |
| Carlton et al. [36] | 2021 | Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand |
| Chen et al. [37] | 2021 | Comparison of public health containment measures of COVID-19 in China and India |
| Chen et al. [38] | 2021 | A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic |
| Chen et al. [39] | 2021 | Policy disparities in response to COVID-19 between China and South Korea |
| Chen et al. [40] | 2021 | The heterogeneity of the COVID-19 pandemic and national responses: an explanatory mixed-methods study |
| Chen et al. [41] | 2022 | China can prepare to end its zero-COVID policy |
| Cheng et al. [42] | 2022 | Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak |
| Cheshmehzangi et al. [43] | 2022 | Commentary: China’s zero-COVID approach depends on Shanghai’s outbreak control |
| Das [44] | 2022 | COVID-19 and the elderlies: how safe are Hong Kong’s care homes? |
| Ding et al. [31] | 2022 | China’s COVID-19 control strategy and its impact on the global pandemic |
| Dyer [45] | 2022 | COVID-19: Lockdowns spread in China as omicron tests “zero COVID” strategy |
| Fitzgerald et al. [46] | 2020 | COVID-19: A tale of two pandemics across the Asia Pacific region |
| Hale et al. [47] | 2021 | A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker) |
| Hassan et al. [48] | 2021 | Hindsight is 2020? Lessons in global health governance one year into the pandemic |
| Islam et al. [9] | 2020 | Variations in COVID strategies: Determinants and lessons |
| Jecker et al. [49] | 2022 | Does Zero-COVID neglect health disparities? |
| König et al. [29] | 2022 | The impact of government responses to the COVID-19 pandemic on GDP growth: does strategy matter? |
| Lee et al. [50] | 2020 | Should countries aim for elimination in the COVID-19 pandemic? |
| Lu et al. [51] | 2021 | COVID-19 in Germany and China: mitigation versus elimination strategy |
| Mallapaty [52] | 2022 | China’s zero-COVID strategy: what happens next? |
| Mason et al. [26] | 2022 | Reduced presentations with fractures or orthopaedic infections to a major children’s hospital during a national COVID-19 elimination strategy |
| McKee [28] | 2020 | Achieving zero COVID is not easy, but the alternative is far worse |
| Müller et al. [53] | 2020 | COVID-19 control: can Germany learn from China? |
| Normile [54] | 2021 | ‘Zero COVID’ is getting harder—but China is sticking with it |
| Normile [55] | 2022 | Can ‘zero COVID’ countries continue to keep the virus at bay once they reopen? |
| Normile [56] | 2022 | China quietly plans a pivot from ‘zero COVID’ |
| Schaefer [57] | 2022 | Zero COVID and health inequities: lessons from Singapore |
| Shimizu et al. [58] | 2021 | Japan should aim to eliminate COVID-19 |
| Shokoohi et al. [59] | 2020 | COVID-19 pandemic: what can the West learn from the East? |
| Stobart et al. [60] | 2022 | Australia’s Response to COVID-19 |
| Taylor [61] | 2022 | COVID-19: Hong Kong reports world’s highest death rate as zero COVID strategy fails |
| Wan et al. [62] | 2022 | Diagnostic strategy of SARS-CoV-2 for containment under China’s zero-COVID-19 policy |
| Wang et al. [63] | 2020 | Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and China |
| Wong et al. [64] | 2022 | Transmission of Omicron (B.1.1.529)—SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 |
| Yang et al. [27] | 2021 | Public health interventions for COVID-19 reduce Kawasaki disease in Taiwan |
| Yuan [61] | 2022 | Zero COVID in China: what next? |
| Zhan et al. [65] | 2022 | Zero-COVID strategy: what’s next? |
| Zhang et al. [66] | 2021 | Policy disparities in response to the first wave of COVID-19 between China and Germany |
| Zhang et al. [67] | 2021 | Policy disparities in response to the first wave of COVID-19 between China and Germany |
| Zhang et al. [68] | 2022 | Asymptomatic transmissibility calls for implementing a Zero-COVID strategy to end the current global crisis |